المؤلفون: De Giorgi U., Carteni G., Giannarelli D., Basso U., Galli L., Cortesi E., Caserta C., Pignata S., Sabbatini R., Bearz A., Buti S., Lo Re G., Berruti A., Bracarda S., Cognetti F., Rastelli F., Fornarini G., Porta C., Turci D., Sternberg C. N., Procopio G., Falcone A., Roila F., Cascinu S., Tirelli U., Giustini L., Sobrero A., Cappuzzo F., Tassinari D., Passalacqua R., Pazzola A., Surico G., Maio M., Benedetti G., Barone C., Adamo V., Ricevuto E., De Censi A., Spada M., Tonini G., Pinto C., Ciuffreda L., Ruggeri E. M., Bengala C., Scotti V., Fagnani D., Bonetti A., Mitterer M., Castiglione F., Bidoli P., Ferrau F., Crino L., Frassoldati A., Marchetti P., Mini E., Scoppola A., Verusio C., Favaretto A., Di Costanzo F., Fasola G., Merlano M., Artioli F., Di Leo A., Romito S., Maestri A., Giannitto Giorgio C., Ionta M. T., Verderame F., Zampa G., Numico G., Minelli M., Tagliaferri P., Foa P., Palmiotti G., De Placido S., Mattioli R., Iuliano F., Defraia E., Siena S., Clerico M., Salvagno L., Ceresoli G. L., Bernardo A., Di Lieto M., Moroni M., Maisano M., Scartozzi M., Scagliotti G., Soraru M., Pepe S., Scaltriti A., Gebbia V., Testa E., Lorusso V., Bordonaro R., De Signoribus G., Tedde N., Santoro A., Francini G., Aondio G.

المساهمون: De Giorgi, U., Carteni, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N., Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Adamo, V., Ricevuto, E., De Censi, A., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Ruggeri, E. M., Bengala, C., Scotti, V., Fagnani, D., Bonetti, A., Mitterer, M., Castiglione, F., Bidoli, P., Ferrau, F., Crino, L., Frassoldati, A., Marchetti, P., Mini, E., Scoppola, A., Verusio, C., Favaretto, A., Di Costanzo, F., Fasola, G., Merlano, M., Artioli, F., Di Leo, A., Romito, S., Maestri, A., Giannitto Giorgio, C., Ionta, M. T., Verderame, F., Zampa, G., Numico, G., Minelli, M., Tagliaferri, P., Foa, P., Palmiotti, G., De Placido, S., Mattioli, R., Iuliano, F., Defraia, E., Siena, S., Clerico, M., Salvagno, L., Ceresoli, G. L., Bernardo, A., Di Lieto, M., Moroni, M., Maisano, M., Scartozzi, M., Scagliotti, G., Soraru, M., Pepe, S., Scaltriti, A., Gebbia, V., Testa, E., Lorusso, V., Bordonaro, R., De Signoribus, G., Tedde, N., Santoro, A., Francini, G., Aondio, G.

مصطلحات موضوعية: expanded access programme, nivolumab, real-world experience, renal cell cancer, Adult, Aged, 80 and over, Antineoplastic Agent, Antineoplastic Agents, Immunological, Bone Neoplasm, Brain Neoplasm, Carcinoma, Renal Cell, Everolimu, Female, Human, Kidney Neoplasm, Male, Middle Aged, Progression-Free Survival, Pyrimidine, Response Evaluation Criteria in Solid Tumor, Retreatment, Sulfonamide, Sunitinib, Survival Rate

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29956884; info:eu-repo/semantics/altIdentifier/wos/WOS:000455329800017; volume:123; issue:1; firstpage:98; lastpage:105; numberofpages:8; journal:BJU INTERNATIONAL; http://hdl.handle.net/11586/327400Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85050678322

الإتاحة: https://doi.org/10.1111/bju.14461Test
http://hdl.handle.net/11586/327400Test

المؤلفون: Pantano F., Santoni M., Procopio G., Rizzo M., Iacovelli R., Porta C., Conti A., Lugini A., Milella M., Galli L., Ortega C., Guida F. M., Silletta M., Schinzari G., Verzoni E., Modica D., Crucitti P., Rauco A., Felici A., Ballatore V., Cascinu S., Tonini G., Carteni G., Russo A., Santini D.

المساهمون: Pantano, F., Santoni, M., Procopio, G., Rizzo, M., Iacovelli, R., Porta, C., Conti, A., Lugini, A., Milella, M., Galli, L., Ortega, C., Guida, F. M., Silletta, M., Schinzari, G., Verzoni, E., Modica, D., Crucitti, P., Rauco, A., Felici, A., Ballatore, V., Cascinu, S., Tonini, G., Carteni, G., Russo, A., Santini, D.

مصطلحات موضوعية: Adolescent, Adult, Antineoplastic Agent, Biomarker, Blood Glucose, Blood Pressure, Body Mass Index, Carcinoma, Renal Cell, Cholesterol, Disease Progression, Everolimu, Human, Kidney Neoplasm, Lipid Metabolism, Neoplasm Staging, Retrospective Studie, Survival Rate, Triglyceride, Young Adult

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25885920; info:eu-repo/semantics/altIdentifier/wos/WOS:000353017000009; volume:10; issue:4 Article Number: e0120427; firstpage:1; lastpage:12; numberofpages:12; journal:PLOS ONE; http://hdl.handle.net/11586/327265Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84929493881

الإتاحة: https://doi.org/10.1371/journal.pone.0120427Test
http://hdl.handle.net/11586/327265Test

المؤلفون: Bracarda S., Iacovelli R., Boni L., Rizzo M., Derosa L., Rossi M., Galli L., Procopio G., Sisani M., Longo F., Santoni M., Morelli F., Di Lorenzo G., Altavilla A., Porta C., Camerini A., Escudier B., Martignetti A., Ricotta R., Gasparro D., Sabbatini R., Ceresoli G. L., Mosca A., Santini D., Caserta C., Cavanna L., Massari F., Sava T., Boni C., Verzoni E., Carteni G., Hamzaj A.

المساهمون: Bracarda, S., Iacovelli, R., Boni, L., Rizzo, M., Derosa, L., Rossi, M., Galli, L., Procopio, G., Sisani, M., Longo, F., Santoni, M., Morelli, F., Di Lorenzo, G., Altavilla, A., Porta, C., Camerini, A., Escudier, B., Martignetti, A., Ricotta, R., Gasparro, D., Sabbatini, R., Ceresoli, G. L., Mosca, A., Santini, D., Caserta, C., Cavanna, L., Massari, F., Sava, T., Boni, C., Verzoni, E., Carteni, G., Hamzaj, A.

مصطلحات موضوعية: mRCC, Sunitinib, Toxicity, Treatment schedule, Adult, Aged, 80 and over, Antineoplastic Agent, Bone Neoplasm, Carcinoma, Papillary, Renal Cell, Female, Follow-Up Studie, Human, Indole, Kidney Neoplasm, Liver Neoplasm, Lung Neoplasm, Male, Middle Aged, Neoplasm Staging, Prognosi, Pyrrole, Retrospective Studie, Survival Rate

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26216384; info:eu-repo/semantics/altIdentifier/wos/WOS:000362844300016; volume:26; issue:10; firstpage:2107; lastpage:2113; numberofpages:7; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11586/327277Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84943774153

الإتاحة: https://doi.org/10.1093/annonc/mdv315Test
http://hdl.handle.net/11586/327277Test

المؤلفون: De Giorgi, U, Carteni, G, Giannarelli, D, Basso, U, Galli, L, Cortesi, E, Caserta, C, Pignata, S, Sabbatini, R, Bearz, A, Buti, S, Lo Re, G, Berruti, A, Bracarda, S, Cognetti, F, Rastelli, F, Fornarini, G, Porta, C, Turci, D, Sternberg, Cn, Procopio, G, Falcone, A, Roila, F, Cascinu, S, Tirelli, U, Giustini, L, Sobrero, A, Cappuzzo, F, Tortora, G, Tassinari, D, Passalacqua, R, Pazzola, A, Surico, G, Maio, M, Benedetti, G, Barone, C, Adamo, V, Ricevuto, E, De Censi, A, Spada, M, Tonini, G, Pinto, C, Ciuffreda, L, Ruggeri, Em, Bengala, C, Scotti, V, Fagnani, D, Bonetti, A, Mitterer, M, Castiglione, F, Bidoli, P, Ferrau, F, Crino, L, Frassoldati, A, Marchetti, P, Mini, E, Scoppola, A, Verusio, C, Favaretto, A, Di Costanzo, F, Fasola, G, Merlano, M, Artioli, F, Di Leo, A, Romito, S, Maestri, A, Giorgio, Cg, Ionta, Mt, Verderame, F, Zampa, G, Numico, G, Minelli, M, Tagliaferri, P, Foa, P, Palmiotti, G, De Placido, S, Mattioli, R, Iuliano, F, Defraia, E, Siena, S, Clerico, M, Salvagno, L, Ceresoli, Gl, Bernardo, A, Di Lieto, M, Moroni, M, Maisano, M, Scartozzi, M, Scagliotti, G, Soraru, M, Pepe, S, Scaltriti, A, Gebbia, V, Testa, E, Lorusso, V, Bordonaro, R, De Signoribus, G, Tedde, N, Santoro, A, Francini, G, Aondio, G

المساهمون: De Giorgi, U., Carteni, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N., Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Adamo, V., Ricevuto, E., De Censi, A., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Ruggeri, E. M., Bengala, C., Scotti, V., Fagnani, D., Bonetti, A., Mitterer, M., Castiglione, F., Bidoli, P., Ferrau, F., Crino, L., Frassoldati, A., Marchetti, P., Mini, E., Scoppola, A., Verusio, C., Favaretto, A., Di Costanzo, F., Fasola, G., Merlano, M., Artioli, F., Di Leo, A., Romito, S., Maestri, A., Giannitto Giorgio, C., Ionta, M. T., Verderame, F., Zampa, G., Numico, G., Minelli, M., Tagliaferri, P., Foa, P., Palmiotti, G., De Placido, S., Mattioli, R., Iuliano, F., Defraia, E., Siena, S., Clerico, M., Salvagno, L., Ceresoli, G. L., Bernardo, A., Di Lieto, M., Moroni, M., Maisano, M., Scartozzi, M., Scagliotti, G., Soraru, M., Pepe, S., Scaltriti, A., Gebbia, V., Testa, E., Lorusso, V., Bordonaro, R., De Signoribus, G., Tedde, N., Santoro, A., Francini, G., Aondio, G., De Giorgi, U, Cartenì, G, Giannarelli, D, Basso, U, Galli, L, Cortesi, E, Caserta, C, Pignata, S, Sabbatini, R, Bearz, A, Buti, S, Lo Re, G, Berruti, A, Bracarda, S, Cognetti, F, Rastelli, F, Fornarini, G, Porta, C, Turci, D, Sternberg, C, Procopio, G, Bidoli, P

مصطلحات موضوعية: 0301 basic medicine, Male, expanded access programme, nivolumab, real-world experience, renal cell cancer, Antineoplastic Agent, 0302 clinical medicine, Antineoplastic Agents, Immunological, 80 and over, Sunitinib, Medicine, Urology, Aged, 80 and over, Sulfonamides, Brain Neoplasms, Kidney Neoplasm, Common Terminology Criteria for Adverse Events, Middle Aged, Kidney Neoplasms, Progression-Free Survival, Survival Rate, Everolimu, Immunological, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Retreatment, Female, Nivolumab, medicine.drug, Human, Adult, medicine.medical_specialty, Indazoles, metastatic renal cancer, Response Evaluation Criteria in Solid Tumor, Antineoplastic Agents, Bone Neoplasms, Bone Neoplasm, expanded access programme, nivolumab, real-world experience, renal cell cancer, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Antineoplastic Agents, Immunological, Bone Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Nivolumab, Progression-Free Survival, Pyrimidines, Response Evaluation Criteria in Solid Tumors, Retreatment, Sulfonamides, Sunitinib, Survival Rate, Sulfonamide, Pazopanib, Brain Neoplasm, 03 medical and health sciences, Aged, Carcinoma, Renal Cell, Everolimus, Humans, Pyrimidines, Internal medicine, Progression-free survival, Survival rate, business.industry, Carcinoma, Renal Cell, 030104 developmental biology, Pyrimidine, Expanded access, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc1bee2a040cf0f99f4bf3071f70212Test
http://hdl.handle.net/2318/1693656Test

المؤلفون: Di Lorenzo G., Sonpavde G., Pond G., Lucarelli G., Rossetti S., Facchini G., Scagliarini S., Carteni G., Federico P., Daniele B., Morelli F., Bellelli T., Ferro M., De Placido S., Buonerba C.

المساهمون: Di Lorenzo, G., Sonpavde, G., Pond, G., Lucarelli, G., Rossetti, S., Facchini, G., Scagliarini, S., Carteni, G., Federico, P., Daniele, B., Morelli, F., Bellelli, T., Ferro, M., De Placido, S., Buonerba, C.

مصطلحات موضوعية: Abiraterone, Prostate cancer, Statin, Abiraterone Acetate, Aged, Antineoplastic Agent, Human, Hydroxymethylglutaryl-CoA Reductase Inhibitor, Kallikrein, Male, Middle Aged, Multivariate Analysi, Neoplasm Metastasi, Prognosi, Proportional Hazards Model, Prostate-Specific Antigen, Prostatic Neoplasms, Castration-Resistant, Retrospective Studie, Survival Rate

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000486148900011; volume:4; issue:6; firstpage:874; lastpage:879; numberofpages:6; journal:EUROPEAN UROLOGY FOCUS; http://hdl.handle.net/11588/789596Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85017217090; http://www.journals.elsevier.com/european-urology-focusTest

الإتاحة: https://doi.org/10.1016/j.euf.2017.03.015Test
http://hdl.handle.net/11588/789596Test
http://www.journals.elsevier.com/european-urology-focusTest

المؤلفون: Gallo M., Malandrino P., Fanciulli G., Rota F., Faggiano A., Colao A., Albertelli M., Amoroso V., Arvat E., Badalamenti G., Bajetta E., Baldelli R., Bianchi A., Botti G., Buzzoni R., Campana D., Carnaghi C., Carteni G., Cingarlini S., Circelli L., Colantuoni V., Coppa J., Corcione F., Dav M. V., De Rosa G., Degli Uberti E., Del Basso De Caro M., Di Sarno A., Falconi M., Ferolla P., Ferone D., Fiore F., Gaudenzi G., Giordano C., Giuffrida D., Grossrubatscher E. M., Guadagno E., Guarnotta V., Izzo F., Lania A., Lastoria S., Leo S., Lo Calzo F., Logoluso F., Manzoni M., Marchetti M., Martini C., Messina E., Milione M., Modica R., Montesarchio V., Muto P., Nappi O., Nazzari E., Panzuto F., Pia A., Piovesan A., Pizza G., Pontecorvi A., Pusceddu S., Razzore P., Riccardi F., Rindi G., Sciammarella C., Spada F., Tafuto S., Versari A., Vitale G., Zatelli M. C.

المساهمون: Gallo M., Malandrino P., Fanciulli G., Rota F., Faggiano A., Colao A., Albertelli M., Amoroso V., Arvat E., Badalamenti G., Bajetta E., Baldelli R., Bianchi A., Botti G., Buzzoni R., Campana D., Carnaghi C., Carteni G., Cingarlini S., Circelli L., Colantuoni V., Coppa J., Corcione F., Dav M.V., De Rosa G., Degli Uberti E., Del Basso De Caro M., Di Sarno A., Falconi M., Ferolla P., Ferone D., Fiore F., Gaudenzi G., Giordano C., Giuffrida D., Grossrubatscher E.M., Guadagno E., Guarnotta V., Izzo F., Lania A., Lastoria S., Leo S., Lo Calzo F., Logoluso F., Manzoni M., Marchetti M., Martini C., Messina E., Milione M., Modica R., Montesarchio V., Muto P., Nappi O., Nazzari E., Panzuto F., Pia A., Piovesan A., Pizza G., Pontecorvi A., Pusceddu S., Razzore P., Riccardi F., Rindi G., Sciammarella C., Spada F., Tafuto S., Versari A., Vitale G., Zatelli M.C.

مصطلحات موضوعية: Everolimu, mTOR inhibitor, Neuroendocrine tumour, Therapy, Antineoplastic Agent, Human, Neuroendocrine Tumor, Pancreatic Neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28405826; info:eu-repo/semantics/altIdentifier/wos/WOS:000404235900011; volume:143; issue:7; firstpage:1209; lastpage:1224; numberofpages:16; journal:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; http://hdl.handle.net/2318/1717727Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85017464796; link.springer.de/link/service/journals/00432/index.htm

الإتاحة: https://doi.org/10.1007/s00432-017-2407-5Test
http://hdl.handle.net/2318/1717727Test

المؤلفون: Ravaud A, Motzer RJ, Pandha HS, George DJ, Pantuck AJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M1, Lin X, Martini JF, Ramaswamy K, Casey M, Staehler M, Patard JJ, Gruenwald V, Link K, Doehn C, Heinzer H, Grimm M-O, Wirth M, Stoeckle M, Heidenreich A, Garcia del Muro Solans X, Mellado BO, Castellano DG, Frydenberg M, Schobinger SR, Dimopoulos MA, Rothermundt C, Climent Duran MA, Melotti B, Procopio G, Boccardo F, Sella A, Stewart S, Adenis A, Jones RJ, Chevreau C, Prausova J, Vyzula R, Oudard S, Jacqmin D, Gravis G, Varela R, Herrmann E, Lim HY, Lee J-L, Kim YH, Kim JH, Ou Y-C, Papakotoulas P, Iacobelli S, Chowdhury S, Passalacqua R, Tomasek J, Anton Aparicio LM, Linassier C, Hauser S, Bergmann L, Hawkins RE, Szczylik C, Zdrojowy R, Sosnowski M, Koralewski P, Wiechnio PJ, Schraml J, Mardiak J, Laurinc P, Kliment J, Rosenbaum E, Lundstam S, Flodgren P, Ljungberg B, Stenzl A, Schnoeller TJ, McDermott SR, Breathnach OS, McCaffrey JA, Donnellan P, The G-C, Rolland F, Brekkan E, Nilsson C, Kim WY, Bishoff J, Chung J, Shore ND, Master V, Tang Chen DY, Ye D, Huang Y, Jin J, Song B, Zhou F, Galceran JC, Yao X, Zhang X.

المساهمون: Ravaud, A, Motzer, Rj, Pandha, H, George, Dj, Pantuck, Aj, Patel, A, Chang, Yh, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Breza, J, Gerletti, P, Lechuga, M1, Lin, X, Martini, Jf, Ramaswamy, K, Casey, M, Staehler, M, Patard, Jj, Gruenwald, V, Link, K, Doehn, C, Heinzer, H, Grimm, M-O, Wirth, M, Stoeckle, M, Heidenreich, A, Garcia del Muro Solans, X, Mellado, Bo, Castellano, Dg, Frydenberg, M, Schobinger, Sr, Dimopoulos, Ma, Rothermundt, C, Climent Duran, Ma, Melotti, B, Procopio, G, Boccardo, F, Sella, A, Stewart, S, Adenis, A, Jones, Rj, Chevreau, C, Prausova, J, Vyzula, R, Oudard, S, Jacqmin, D, Gravis, G, Varela, R, Herrmann, E, Lim, Hy, Lee, J-L, Kim, Yh, Kim, Jh, Ou, Y-C, Papakotoulas, P, Iacobelli, S, Chowdhury, S, Passalacqua, R, Tomasek, J, Anton Aparicio, Lm, Linassier, C, Hauser, S, Bergmann, L, Hawkins, Re, Szczylik, C, Zdrojowy, R, Sosnowski, M, Koralewski, P, Wiechnio, Pj, Schraml, J, Mardiak, J, Laurinc, P, Kliment, J, Rosenbaum, E, Lundstam, S, Flodgren, P, Ljungberg, B, Stenzl, A, Schnoeller, Tj, Mcdermott, Sr, Breathnach, O, Mccaffrey, Ja, Donnellan, P, The, G-C, Rolland, F, Brekkan, E, Nilsson, C, Kim, Wy, Bishoff, J, Chung, J, Shore, Nd, Master, V, Tang Chen, Dy, Ye, D, Huang, Y, Jin, J

مصطلحات موضوعية: Adolescent, Adult, Aged, 80 and over, Antineoplastic Agent, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Double-Blind Method, Drug Administration Schedule, Female, Human, Indole, Kidney Neoplasm, Male, Middle Aged, Pyrrole, Survival Analysi, Young Adult, Nephrectomy, Medicine (all)

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27718781; info:eu-repo/semantics/altIdentifier/wos/WOS:000389310000007; volume:375; firstpage:2246; lastpage:2254; numberofpages:9; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11567/859354Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85003550836

الإتاحة: https://doi.org/10.1056/NEJMoa1611406Test
http://hdl.handle.net/11567/859354Test

المؤلفون: Sternberg C. N., Calabro F., Bracarda S., Carteni G., Lo Re G., Ruggeri E. M., Basso U., GASPARINI, GIULIA, Ciuffreda L., Ferrari V., Bonetti A., Fea E., Gasparro D., Tassinari D., Labianca R., Masini C., Fly K., Zhang K., Hariharan S., Capaccetti B., Porta C.

المساهمون: Sternberg, C. N., Calabro, F., Bracarda, S., Carteni, G., Lo Re, G., Ruggeri, E. M., Basso, U., Gasparini, Giulia, Ciuffreda, L., Ferrari, V., Bonetti, A., Fea, E., Gasparro, D., Tassinari, D., Labianca, R., Masini, C., Fly, K., Zhang, K., Hariharan, S., Capaccetti, B., Porta, C.

مصطلحات موضوعية: Expanded-access program, Receptor tyrosine kinase inhibitor, Renal cell carcinoma, Safety, Sunitinib malate, Survival, Adult, Aged, Anemia, Antineoplastic Agent, Asthenia, Carcinoma, Renal Cell, Compassionate Use Trial, Diarrhea, Disease-Free Survival, Drug Administration Schedule, Dysgeusia, Female, Follow-Up Studie, Human, Hypertension, Incidence, Indole, Italy, Kaplan-Meier Estimate, Kidney Neoplasm, Leukopenia, Male, Middle Aged

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25592399; info:eu-repo/semantics/altIdentifier/wos/WOS:000353722800002; volume:88; issue:5; firstpage:273; lastpage:280; numberofpages:8; journal:ONCOLOGY; http://hdl.handle.net/11571/1302968Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84929031139; www.karger.com/journals/ocl/ocl_jh.htm

الإتاحة: https://doi.org/10.1159/000369256Test
http://hdl.handle.net/11571/1302968Test

المؤلفون: Gore M. E., Szczylik C., Porta C., Bracarda S., Bjarnason G. A., Oudard S., Lee S. -H., Haanen J., Castellano D., Vrdoljak E., Schoffski P., Mainwaring P., Hawkins R. E., Crino L., Kim T. M., Carteni G., Eberhardt W. E. E., Zhang K., Fly K., Matczak E., Lechuga M. J., Hariharan S., Bukowski R.

المساهمون: Gore, M. E., Szczylik, C., Porta, C., Bracarda, S., Bjarnason, G. A., Oudard, S., Lee, S. -H., Haanen, J., Castellano, D., Vrdoljak, E., Schoffski, P., Mainwaring, P., Hawkins, R. E., Crino, L., Kim, T. M., Carteni, G., Eberhardt, W. E. E., Zhang, K., Fly, K., Matczak, E., Lechuga, M. J., Hariharan, S., Bukowski, R.

مصطلحات موضوعية: expanded-access trial, prognosi, Renal cell carcinoma, sunitinib, tyrosine kinase inhibitor, Adult, Aged, 80 and over, Antineoplastic Agent, Carcinoma, Renal Cell, Female, Human, Indole, Kidney Neoplasm, Male, Middle Aged, Pyrrole, Young Adult, Neoplasm Metastasis

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26086878; info:eu-repo/semantics/altIdentifier/wos/WOS:000357188500003; volume:113; issue:1; firstpage:12; lastpage:19; numberofpages:8; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/11571/1302906Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84934444813; http://www.nature.com/bjc/index.htmlTest

الإتاحة: https://doi.org/10.1038/bjc.2015.196Test
http://hdl.handle.net/11571/1302906Test
http://www.nature.com/bjc/index.htmlTest

المؤلفون: De Marinis, Filippo, Ardizzoni, Andrea, Fontanini, Gabriella, Grossi, Francesco, Cappuzzo, Federico, Novello, Silvia, Santo, Antonio, Lorusso, Vito, Cortinovis, Diego, Iurlaro, Monica, Galetta, Domenico, Gridelli, Cesare, Pedrazzoli P, Siena S, Alabiso O, Bilancia D, Cinieri S, Cartenì G, Fasola G, Ferraù F, Milella M, Contu A, Giuffrida D, Illiano A, Ravaioli A, Zaniboni A, Bettini A, Caprioli A, Longo F, Cruciani G, Defraia E, Favaretto A, Amadori D, Clerico M, Di Costanzo F, Gamucci T, Caruso M, Iacobelli S, Pinotti G, Pozzessere D, Maiello E, Marchetti P, Passalacqua R, Pavesi L, Tortora G, Aglietta M, Brandes A, Ciuffreda L, Daniele B, Demichelis C, Romito S, Tamberi S, Barni S, Barbieri F, Giordano M, Bracarda S, Crinò L, Marzano N, Merlano M, Numico G., BIANCO, ROBERTO

المساهمون: De Marinis, Filippo, Ardizzoni, Andrea, Fontanini, Gabriella, Grossi, Francesco, Cappuzzo, Federico, Novello, Silvia, Santo, Antonio, Lorusso, Vito, Cortinovis, Diego, Iurlaro, Monica, Galetta, Domenico, Gridelli, Cesare, Pedrazzoli, P, Siena, S, Alabiso, O, Bilancia, D, Cinieri, S, Cartenì, G, Fasola, G, Ferraù, F, Milella, M, Contu, A, Giuffrida, D, Illiano, A, Ravaioli, A, Zaniboni, A, Bettini, A, Caprioli, A, Longo, F, Cruciani, G, Defraia, E, Favaretto, A, Amadori, D, Clerico, M, Di Costanzo, F, Gamucci, T, Caruso, M, Iacobelli, S, Pinotti, G, Pozzessere, D, Maiello, E, Marchetti, P, Passalacqua, R, Pavesi, L, Tortora, G, Aglietta, M, Bianco, Roberto, Brandes, A, Ciuffreda, L, Daniele, B, Demichelis, C, Romito, S, Tamberi, S, Barni, S, Barbieri, F, Giordano, M, Bracarda, S, Crinò, L, Marzano, N, Merlano, M, Numico, G.

مصطلحات موضوعية: Chemotherapy, EGFR, Erlotinib, NSCLC, Third-line, Adult, Aged, 80 and over, Antineoplastic Agent, Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung, Cohort Studie, Disease Progression, Erlotinib Hydrochloride, Female, Human, Italy, Longitudinal Studie, Lung Neoplasm, Male, Middle Aged, Mutation, Proto-Oncogene Protein, Quinazoline, Receptor Protein-Tyrosine Kinase, Receptor, Epidermal Growth Factor, ras Protein

العلاقة: volume:15; issue:5; firstpage:338; lastpage:345.e1; journal:CLINICAL LUNG CANCER; http://hdl.handle.net/11588/658178Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84908240361; http://www.journals.elsevier.com/clinical-lung-cancerTest/

الإتاحة: https://doi.org/10.1016/j.cllc.2014.04.004Test
http://hdl.handle.net/11588/658178Test
http://www.journals.elsevier.com/clinical-lung-cancerTest/